메뉴 건너뛰기




Volumn 38, Issue , 2015, Pages S33-S40

6. Glycemic targets
[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

EID: 84929145647     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc15-S009     Document Type: Article
Times cited : (185)

References (57)
  • 1
    • 0027370108 scopus 로고
    • The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
    • The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.N Engl JMed 1993;329:977-986
    • (1993) N Engl JMed , vol.329 , pp. 977-986
  • 2
    • 84875181139 scopus 로고    scopus 로고
    • Evidence of a strong association between frequency of selfmonitoring of blood glucose and hemoglobin A1c levels in T1D Exchange clinic registry participants
    • Miller KM, Beck RW, Bergenstal RM, et al.; T1D Exchange Clinic Network. Evidence of a strong association between frequency of selfmonitoring of blood glucose and hemoglobin A1c levels in T1D Exchange clinic registry participants. Diabetes Care 2013;36:2009-2014
    • (2013) Diabetes Care , vol.36 , pp. 2009-2014
    • Miller, K.M.1    Beck, R.W.2    Bergenstal, R.M.3
  • 3
    • 80051988751 scopus 로고    scopus 로고
    • Position statement executive summary: Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus
    • Sacks DB, ArnoldM, Bakris GL, et al.; National Academy of Clinical Biochemistry. Position statement executive summary: guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care 2011;34:1419-1423
    • (2011) Diabetes Care , vol.34 , pp. 1419-1423
    • National Academy of Clinical Biochemistry1    Sacks, D.B.2    Arnold, M.3    Bakris, G.L.4
  • 4
    • 84858965920 scopus 로고    scopus 로고
    • Selfmonitoring of blood glucose is associated with problem-solving skills in hyperglycemia and hypoglycemia
    • Wang J, Zgibor J, Matthews JT, Charron-Prochownik D, Sereika SM, Siminerio L. Selfmonitoring of blood glucose is associated with problem-solving skills in hyperglycemia and hypoglycemia. Diabetes Educ 2012;38:207-218
    • (2012) Diabetes Educ , vol.38 , pp. 207-218
    • Wang, J.1    Zgibor, J.2    Matthews, J.T.3    Charron-Prochownik, D.4    Sereika, S.M.5    Siminerio, L.6
  • 5
    • 79951717523 scopus 로고    scopus 로고
    • Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: Results from the Structured Testing Program study
    • Polonsky WH, Fisher L, Schikman CH, et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study. Diabetes Care 2011;34:262-267
    • (2011) Diabetes Care , vol.34 , pp. 262-267
    • Polonsky, W.H.1    Fisher, L.2    Schikman, C.H.3
  • 7
    • 34447636939 scopus 로고    scopus 로고
    • Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: Open parallel group randomised trial
    • Farmer A, Wade A, Goyder E, et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ 2007;335:132
    • (2007) BMJ , vol.335 , pp. 132
    • Farmer, A.1    Wade, A.2    Goyder, E.3
  • 8
    • 44449103216 scopus 로고    scopus 로고
    • Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): Randomised controlled trial
    • O'Kane MJ, Bunting B, Copeland M, Coates VE; ESMON Study Group. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ 2008;336: 1174-1177
    • (2008) BMJ , vol.336 , pp. 1174-1177
    • O'Kane, M.J.1    Bunting, B.2    Copeland, M.3    Coates, V.E.4
  • 9
    • 44449096635 scopus 로고    scopus 로고
    • Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: Economic evaluation of data from the DiGEM trial
    • Simon J, Gray A, Clarke P, Wade A, Neil A, Farmer A; Diabetes Glycaemic Education and Monitoring Trial Group. Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial. BMJ 2008;336:1177-1180
    • (2008) BMJ , vol.336 , pp. 1177-1180
    • Simon, J.1    Gray, A.2    Clarke, P.3    Wade, A.4    Neil, A.5    Farmer, A.6
  • 10
    • 84862746531 scopus 로고    scopus 로고
    • Meta-analysis: Self-monitoring in non-insulin-treated type 2 diabetes improved HbA1c by 0.25%
    • Willett LR. ACP Journal Club. Meta-analysis: self-monitoring in non-insulin-treated type 2 diabetes improved HbA1c by 0.25%. Ann Intern Med 2012;156:JC6-JC12
    • (2012) Ann Intern Med , vol.156 , pp. JC6-JC12
    • ACP Journal Club1    Willett, L.R.2
  • 12
    • 54849147700 scopus 로고    scopus 로고
    • Continuous glucose monitoring and intensive treatment of type 1 diabetes
    • Tamborlane WV, Beck RW, Bode BW, et al.; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-1476
    • (2008) N Engl J Med , vol.359 , pp. 1464-1476
    • Tamborlane, W.V.1    Beck, R.W.2    Bode, B.W.3
  • 13
    • 84908164031 scopus 로고    scopus 로고
    • Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry
    • Wong JC, Foster NC, Maahs DM, et al.; T1D Exchange Clinic Network. Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. Diabetes Care 2014;37:2702-2709
    • (2014) Diabetes Care , vol.37 , pp. 2702-2709
    • T1D Exchange Clinic Network1    Wong, J.C.2    Foster, N.C.3    Maahs, D.M.4
  • 14
    • 84919464732 scopus 로고    scopus 로고
    • Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: Analyses from the SWITCH study
    • Hommel E, Olsen B, Battelino T, et al.; SWITCH Study Group. Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study. Acta Diabetol 2014;51:845-851
    • (2014) Acta Diabetol , vol.51 , pp. 845-851
    • Hommel, E.1    Olsen, B.2    Battelino, T.3
  • 16
    • 68149136644 scopus 로고    scopus 로고
    • The effect of continuous glucose monitoring in well-controlled type 1 diabetes
    • Beck RW, Hirsch IB, Laffel L, et al.; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009;32:1378-1383
    • (2009) Diabetes Care , vol.32 , pp. 1378-1383
    • Beck, R.W.1    Hirsch, I.B.2    Laffel, L.3
  • 17
    • 84868112851 scopus 로고    scopus 로고
    • Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: A systematic review and metaanalysis
    • Yeh H-C, Brown TT, Maruthur N, et al. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and metaanalysis. Ann Intern Med 2012;157:336-347
    • (2012) Ann Intern Med , vol.157 , pp. 336-347
    • Yeh, H.-C.1    Brown, T.T.2    Maruthur, N.3
  • 18
    • 84891885354 scopus 로고    scopus 로고
    • Real-time continuous glucose monitoring significantly reduces severe hypoglycemia in hypoglycemia-unaware patients with type 1 diabetes
    • Choudhary P, Ramasamy S, Green L, et al. Real-time continuous glucose monitoring significantly reduces severe hypoglycemia in hypoglycemia-unaware patients with type 1 diabetes. Diabetes Care 2013;36:4160-4162
    • (2013) Diabetes Care , vol.36 , pp. 4160-4162
    • Choudhary, P.1    Ramasamy, S.2    Green, L.3
  • 19
    • 84880274350 scopus 로고    scopus 로고
    • Threshold-based insulin-pump interruption for reduction of hypoglycemia
    • Bergenstal RM, Klonoff DC, Garg SK, et al.; ASPIRE In-Home Study Group. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 2013;369:224-232
    • (2013) N Engl J Med , vol.369 , pp. 224-232
    • Bergenstal, R.M.1    Klonoff, D.C.2    Garg, S.K.3
  • 20
    • 84910152231 scopus 로고    scopus 로고
    • Frequency of continuous glucose monitoring use and change in hemoglobin A1c for adults with type 1 diabetes in a clinical practice setting
    • McQueen RB, Ellis SL, Maahs DM, Anderson HD, Nair KV, Campbell JD. Frequency of continuous glucose monitoring use and change in hemoglobin A1c for adults with type 1 diabetes in a clinical practice setting. Endocr Pract 2014;20: 1007-1015
    • (2014) Endocr Pract , vol.20 , pp. 1007-1015
    • McQueen, R.B.1    Ellis, S.L.2    Maahs, D.M.3    Anderson, H.D.4    Nair, K.V.5    Campbell, J.D.6
  • 21
    • 84897910481 scopus 로고    scopus 로고
    • Empirically establishing blood glucose targets to achieve HbA1c goals
    • Wei N, Zheng H, Nathan DM. Empirically establishing blood glucose targets to achieve HbA1c goals. Diabetes Care 2014;37:1048-1051
    • (2014) Diabetes Care , vol.37 , pp. 1048-1051
    • Wei, N.1    Zheng, H.2    Nathan, D.M.3
  • 22
    • 77954966171 scopus 로고    scopus 로고
    • Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) study
    • Albers JW, Herman WH, Pop-Busui R, et al.; Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Research Group. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) study. Diabetes Care 2010;33:1090-1096
    • (2010) Diabetes Care , vol.33 , pp. 1090-1096
    • Albers, J.W.1    Herman, W.H.2    Pop-Busui, R.3
  • 23
    • 0034641568 scopus 로고    scopus 로고
    • Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
    • Stratton IM, Adler AI, Neil HAW, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-412
    • (2000) BMJ , vol.321 , pp. 405-412
    • Stratton, I.M.1    Adler, A.I.2    Neil, H.A.W.3
  • 24
    • 79951692033 scopus 로고    scopus 로고
    • Frequent monitoring of A1C during pregnancy as a treatment tool to guide therapy
    • Jovanovič L, Savas H, Mehta M, Trujillo A, Pettitt DJ. Frequent monitoring of A1C during pregnancy as a treatment tool to guide therapy. Diabetes Care 2011;34:53-54
    • (2011) Diabetes Care , vol.34 , pp. 53-54
    • Jovanovič, L.1    Savas, H.2    Mehta, M.3    Trujillo, A.4    Pettitt, D.J.5
  • 25
    • 48149095259 scopus 로고    scopus 로고
    • Translating the A1C assay into estimated average glucose values
    • Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ; A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008;31:1473-1478
    • (2008) Diabetes Care , vol.31 , pp. 1473-1478
    • Nathan, D.M.1    Kuenen, J.2    Borg, R.3    Zheng, H.4    Schoenfeld, D.5    Heine, R.J.6
  • 26
    • 44449120061 scopus 로고    scopus 로고
    • Relationship of A1C to glucose concentrations in children with type 1 diabetes: Assessments by high-frequency glucose determinations by sensors
    • Wilson DM, Kollman; Diabetes Research in Children Network (DirecNet) Study Group. Relationship of A1C to glucose concentrations in children with type 1 diabetes: assessments by high-frequency glucose determinations by sensors. Diabetes Care 2008;31:381-385
    • (2008) Diabetes Care , vol.31 , pp. 381-385
    • Wilson, D.M.1    Kollman2
  • 27
    • 84873811373 scopus 로고    scopus 로고
    • Diabetes screening with hemoglobin A(1c) versus fasting plasma glucose in a multiethnic middleschool cohort
    • Buse JB, Kaufman FR, Linder B, Hirst K, El Ghormli L, Willi S; HEALTHY Study Group. Diabetes screening with hemoglobin A(1c) versus fasting plasma glucose in a multiethnic middleschool cohort. Diabetes Care 2013;36:429-435
    • (2013) Diabetes Care , vol.36 , pp. 429-435
    • Buse, J.B.1    Kaufman, F.R.2    Linder, B.3    Hirst, K.4    El Ghormli, L.5    Willi, S.6
  • 28
    • 77954922283 scopus 로고    scopus 로고
    • Racial disparity in A1C independent of mean blood glucose in children with type 1 diabetes
    • Kamps JL, Hempe JM, Chalew SA. Racial disparity in A1C independent of mean blood glucose in children with type 1 diabetes. Diabetes Care 2010;33:1025-1027
    • (2010) Diabetes Care , vol.33 , pp. 1025-1027
    • Kamps, J.L.1    Hempe, J.M.2    Chalew, S.A.3
  • 29
    • 0034628425 scopus 로고    scopus 로고
    • Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy
    • The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000;342:381-389
    • (2000) N Engl J Med , vol.342 , pp. 381-389
  • 30
    • 33645700675 scopus 로고    scopus 로고
    • Neuropathy among the Diabetes Control and Complications Trial cohort 8 years after trial completion
    • Martin CL, Albers J, Herman WH, et al.; DCCT/EDIC Research Group. Neuropathy among the Diabetes Control and Complications Trial cohort 8 years after trial completion. Diabetes Care 2006;29:340-344
    • (2006) Diabetes Care , vol.29 , pp. 340-344
    • Martin, C.L.1    Albers, J.2    Herman, W.H.3
  • 31
    • 0029147687 scopus 로고
    • Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study
    • Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103-117
    • (1995) Diabetes Res Clin Pract , vol.28 , pp. 103-117
    • Ohkubo, Y.1    Kishikawa, H.2    Araki, E.3
  • 32
    • 0032511566 scopus 로고    scopus 로고
    • Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
    • UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-865
    • (1998) Lancet , vol.352 , pp. 854-865
  • 33
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood-glucose controlwith sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    • UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose controlwith sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853
    • (1998) Lancet , vol.352 , pp. 837-853
  • 35
    • 58149389215 scopus 로고    scopus 로고
    • Glucose control and vascular complications in veterans with type 2 diabetes
    • Duckworth W, Abraira C, Moritz T, et al.; VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129-139
    • (2009) N Engl J Med , vol.360 , pp. 129-139
    • Duckworth, W.1    Abraira, C.2    Moritz, T.3
  • 36
    • 45149133036 scopus 로고    scopus 로고
    • Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
    • Patel A, MacMahon S, Chalmers J, et al.; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-2572
    • (2008) N Engl J Med , vol.358 , pp. 2560-2572
    • Patel, A.1    MacMahon, S.2    Chalmers, J.3
  • 37
    • 77955585592 scopus 로고    scopus 로고
    • Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: An analysis of the ACCORD randomised trial
    • Ismail-Beigi F, Craven T, Banerji MA, et al.; ACCORD trial group. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 2010;376: 419-430
    • (2010) Lancet , vol.376 , pp. 419-430
    • Ismail-Beigi, F.1    Craven, T.2    Banerji, M.A.3
  • 38
    • 0034641550 scopus 로고    scopus 로고
    • Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): Prospective observational study
    • Adler AI, Stratton IM, Neil HAW, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000;321:412-419
    • (2000) BMJ , vol.321 , pp. 412-419
    • Adler, A.I.1    Stratton, I.M.2    Neil, H.A.W.3
  • 39
    • 45149131667 scopus 로고    scopus 로고
    • Effects of intensive glucose lowering in type 2 diabetes
    • Gerstein HC, Miller ME, Byington RP, et al.; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559
    • (2008) N Engl J Med , vol.358 , pp. 2545-2559
    • Gerstein, H.C.1    Miller, M.E.2    Byington, R.P.3
  • 40
    • 29144453326 scopus 로고    scopus 로고
    • Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
    • Nathan DM, Cleary PA, Backlund J-YC, et al.; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-2653
    • (2005) N Engl J Med , vol.353 , pp. 2643-2653
    • Nathan, D.M.1    Cleary, P.A.2    Backlund, J.-Y.C.3
  • 41
    • 67749084303 scopus 로고    scopus 로고
    • Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications and Pittsburgh Epidemiology of Diabetes Complications Experience (1983-2005)
    • Nathan DM, Zinman B, Cleary PA, et al.; Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications and Pittsburgh Epidemiology of Diabetes Complications Experience (1983-2005). Arch Intern Med 2009;169:1307-1316
    • (2009) Arch Intern Med , vol.169 , pp. 1307-1316
    • Nathan, D.M.1    Zinman, B.2    Cleary, P.A.3
  • 42
    • 63149103614 scopus 로고    scopus 로고
    • Intensive glycemic control and the prevention of cardiovascular events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
    • Skyler JS, Bergenstal R, Bonow RO, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care 2009;32:187-192
    • (2009) Diabetes Care , vol.32 , pp. 187-192
    • Skyler, J.S.1    Bergenstal, R.2    Bonow, R.O.3
  • 43
    • 70349881450 scopus 로고    scopus 로고
    • Intensive glucose control and macrovascular outcomes in type 2 diabetes
    • Turnbull FM, Abraira C, Anderson RJ, et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 2009;52:2288-2298
    • (2009) Diabetologia , vol.52 , pp. 2288-2298
    • Turnbull, F.M.1    Abraira, C.2    Anderson, R.J.3
  • 44
    • 82955247825 scopus 로고    scopus 로고
    • The duration of diabetes affects the response to intensive glucose control in type 2 subjects: The VA Diabetes Trial
    • Duckworth WC, Abraira C, Moritz TE, et al.; Investigators of the VADT. The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA Diabetes Trial. J Diabetes Complications 2011;25:355-361
    • (2011) J Diabetes Complications , vol.25 , pp. 355-361
    • Duckworth, W.C.1    Abraira, C.2    Moritz, T.E.3
  • 45
    • 84919999219 scopus 로고    scopus 로고
    • Management of hyperglycemia in type 2 diabetes, 2015: A patient-centered approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes
    • Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015; 38:140-149
    • (2015) Diabetes Care , vol.38 , pp. 140-149
    • Inzucchi, S.E.1    Bergenstal, R.M.2    Buse, J.B.3
  • 47
    • 0037015288 scopus 로고    scopus 로고
    • Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: Effects of short-and long-term simvastatin treatment
    • Ceriello A, Taboga C, Tonutti L, et al. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short-and long-term simvastatin treatment. Circulation 2002;106:1211-1218
    • (2002) Circulation , vol.106 , pp. 1211-1218
    • Ceriello, A.1    Taboga, C.2    Tonutti, L.3
  • 48
    • 64749114318 scopus 로고    scopus 로고
    • Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: The HEART2D trial
    • Raz I, Wilson PWF, Strojek K, et al. Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial. Diabetes Care 2009;32:381-386
    • (2009) Diabetes Care , vol.32 , pp. 381-386
    • Raz, I.1    Wilson, P.W.F.2    Strojek, K.3
  • 49
    • 0036020278 scopus 로고    scopus 로고
    • Hypoglycaemia: The limiting factor in the glycaemicmanagement of type I and type II diabetes
    • Cryer PE. Hypoglycaemia: the limiting factor in the glycaemicmanagement of type I and type II diabetes. Diabetologia 2002;45:937-948
    • (2002) Diabetologia , vol.45 , pp. 937-948
    • Cryer, P.E.1
  • 50
    • 64749114159 scopus 로고    scopus 로고
    • Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus
    • Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP Jr, Selby JV. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009;301:1565-1572
    • (2009) JAMA , vol.301 , pp. 1565-1572
    • Whitmer, R.A.1    Karter, A.J.2    Yaffe, K.3    Quesenberry, C.P.4    Selby, J.V.5
  • 51
    • 84862081563 scopus 로고    scopus 로고
    • Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: Post hoc epidemiologic analysis of the ACCORD trial
    • Punthakee Z, Miller ME, Launer LJ, et al.; ACCORD Group of Investigators; ACCORDMIND Investigators. Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care 2012;35:787-793
    • (2012) Diabetes Care , vol.35 , pp. 787-793
    • Punthakee, Z.1    Miller, M.E.2    Launer, L.J.3
  • 52
    • 34247863937 scopus 로고    scopus 로고
    • Long-term effect of diabetes and its treatment on cognitive function
    • Jacobson AM, Musen G, Ryan CM, et al.; Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Study Research Group. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 2007;356:1842-1852
    • (2007) N Engl J Med , vol.356 , pp. 1842-1852
    • Jacobson, A.M.1    Musen, G.2    Ryan, C.M.3
  • 53
    • 77957742069 scopus 로고    scopus 로고
    • Severe hypoglycemia and risks of vascular events and death
    • Zoungas S, Patel A, Chalmers J, et al.; ADVANCE Collaborative Group. Severe hypoglycemia and risks of vascular events and death. N Engl J Med 2010;363:1410-1418
    • (2010) N Engl J Med , vol.363 , pp. 1410-1418
    • Zoungas, S.1    Patel, A.2    Chalmers, J.3
  • 55
    • 84876796916 scopus 로고    scopus 로고
    • Hypoglycemia and diabetes: A report of a workgroup of the American Diabetes Association and the Endocrine Society
    • Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 2013;36:1384-1395
    • (2013) Diabetes Care , vol.36 , pp. 1384-1395
    • Seaquist, E.R.1    Anderson, J.2    Childs, B.3
  • 56
    • 2442710176 scopus 로고    scopus 로고
    • Diverse causes of hypoglycemiaassociated autonomic failure in diabetes
    • Cryer PE. Diverse causes of hypoglycemiaassociated autonomic failure in diabetes. N Engl J Med 2004;350:2272-2279
    • (2004) N Engl J Med , vol.350 , pp. 2272-2279
    • Cryer, P.E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.